What was the overall market valuation for the clinical trials market in 2024?

The overall market valuation for the clinical trials market was $2639.2 Million in 2024. Read More

What is the projected market valuation for 2035?

The projected market valuation for 2035 is $4223.6 Million. Read More

What is the expected CAGR for the clinical trials market during the forecast period 2025 - 2035?

The expected CAGR for the clinical trials market during the forecast period 2025 - 2035 is 4.37%. Read More

Which companies are considered key players in the clinical trials market?

Key players in the clinical trials market include Covance, IQVIA, PPD, Charles River Laboratories, Medpace, Syneos Health, Parexel International, Wuxi AppTec, and KCR. Read More

What are the market valuations for Phase I clinical trials?

The market valuations for Phase I clinical trials ranged from $500.0 Million to $800.0 Million. Read More

How much is the market expected to grow in the oncology therapeutic area?

The market for the oncology therapeutic area is expected to grow between $800.0 Million and $1300.0 Million. Read More

What is the valuation range for interventional study design in the clinical trials market?

The valuation range for interventional study design is between $1200.0 Million and $1900.0 Million. Read More

What are the projected valuations for Phase III clinical trials?

The projected valuations for Phase III clinical trials range from $900.0 Million to $1400.0 Million. Read More

What is the expected market size for biotechnology companies in the clinical trials market?

The expected market size for biotechnology companies is projected to be between $790.0 Million and $1300.0 Million. Read More

What is the valuation range for expanded access study design?

The valuation range for expanded access study design is between $639.2 Million and $1023.6 Million. Read More

South America Clinical Trials Market

ID: MRFR/MED/48509-HCR

200 Pages

Rahul Gotadki

Last Updated: April 06, 2026

South America Clinical Trials Market Research Report: Size, Share, Trend Analysis By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Therapeutic Area (Oncology, Cardiology, Neurology, Infectious Diseases, Endocrinology), By End Use (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations) and By Regional (Brazil, Mexico, Argentina, Rest of South America) - Growth Outlook & Industry Forecast 2025 To 2035

South America Clinical Trials Market Infographic

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Medical Device, BY Phase (USD Million)
  1. 4.1.1 Phase I
  2. 4.1.2 Phase II
  3. 4.1.3 Phase III
  4. 4.1.4 Phase IV
2. 4.2 Medical Device, BY Study Design (USD Million)
  1. 4.2.1 Interventional
  2. 4.2.2 Observational
  3. 4.2.3 Expanded Access
3. 4.3 Medical Device, BY Therapeutic Area (USD Million)
  1. 4.3.1 Oncology
  2. 4.3.2 Cardiology
  3. 4.3.3 Neurology
  4. 4.3.4 Infectious Diseases
  5. 4.3.5 Endocrinology
4. 4.4 Medical Device, BY End Use (USD Million)
  1. 4.4.1 Pharmaceutical Companies
  2. 4.4.2 Biotechnology Companies
  3. 4.4.3 Contract Research Organizations
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Medical Device
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Medical Device
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Covance (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 IQVIA (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 PPD (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Charles River Laboratories (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Medpace (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Syneos Health (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Parexel International (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Wuxi AppTec (CN)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 KCR (PL)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH AMERICA MARKET ANALYSIS BY PHASE
3. 6.3 SOUTH AMERICA MARKET ANALYSIS BY STUDY DESIGN
4. 6.4 SOUTH AMERICA MARKET ANALYSIS BY THERAPEUTIC AREA
5. 6.5 SOUTH AMERICA MARKET ANALYSIS BY END USE
6. 6.6 KEY BUYING CRITERIA OF MEDICAL DEVICE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF MEDICAL DEVICE
9. 6.9 DRIVERS IMPACT ANALYSIS: MEDICAL DEVICE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: MEDICAL DEVICE
11. 6.11 SUPPLY / VALUE CHAIN: MEDICAL DEVICE
12. 6.12 MEDICAL DEVICE, BY PHASE, 2024 (% SHARE)
13. 6.13 MEDICAL DEVICE, BY PHASE, 2024 TO 2035 (USD Million)
14. 6.14 MEDICAL DEVICE, BY STUDY DESIGN, 2024 (% SHARE)
15. 6.15 MEDICAL DEVICE, BY STUDY DESIGN, 2024 TO 2035 (USD Million)
16. 6.16 MEDICAL DEVICE, BY THERAPEUTIC AREA, 2024 (% SHARE)
17. 6.17 MEDICAL DEVICE, BY THERAPEUTIC AREA, 2024 TO 2035 (USD Million)
18. 6.18 MEDICAL DEVICE, BY END USE, 2024 (% SHARE)
19. 6.19 MEDICAL DEVICE, BY END USE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PHASE, 2025-2035 (USD Million)
  2. 7.2.2 BY STUDY DESIGN, 2025-2035 (USD Million)
  3. 7.2.3 BY THERAPEUTIC AREA, 2025-2035 (USD Million)
  4. 7.2.4 BY END USE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South America Medical Device Market Segmentation

Medical Device By Phase (USD Million, 2025-2035)

Phase I
Phase II
Phase III
Phase IV

Medical Device By Study Design (USD Million, 2025-2035)

Interventional
Observational
Expanded Access

Medical Device By Therapeutic Area (USD Million, 2025-2035)

Oncology
Cardiology
Neurology
Infectious Diseases
Endocrinology

Medical Device By End Use (USD Million, 2025-2035)

Pharmaceutical Companies
Biotechnology Companies
Contract Research Organizations

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”